4.5 Letter

Feasibility of Emulating Clinical Trials Supporting US FDA Supplemental Indication Approvals of Drugs and Biologics

期刊

JAMA INTERNAL MEDICINE
卷 -, 期 -, 页码 -

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamainternmed.2023.4073

关键词

-

向作者/读者索取更多资源

This study evaluates the clinical trial support for supplemental new drug applications and supplemental biologics license applications from 2017 to 2019.
This cross-sectional study evaluates the supporting clinical trials for supplemental new drug applications and supplemental biologics license applications from 2017 to 2019.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据